Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

SciSparc Ltd

SPRC
0,33
0,0015 (0,46%)
Pre Mercato
Ultimo aggiornamento: 14:08:53
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/3/202522:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/3/202522:00EDGAR2Form D - Notice of Exempt Offering of Securities
03/3/202514:25GLOBESciSparc Signs Definitive Agreement to Sell MitoCareX,..
27/2/202522:10EDGAR2Form 425 - Prospectuses and communications, business..
27/2/202522:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/2/202514:45GLOBESciSparc Extends $2 Million Loan to Support AutoMax's Growth..
26/2/202515:29GLOBEN2OFF Signs Definitive Agreement to Acquire Next-Gen..
18/2/202522:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/2/202513:17GLOBESciSparc Secures Favorable Settlement in Lawsuit It Filed,..
13/2/202522:01EDGAR2Form F-4/A - Registration of securities, foreign private..
04/2/202522:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/2/202515:00GLOBESciSparc-Clearmind Collaboration Leads to Publication of..
21/1/202522:05EDGAR2Form POS AM - Post-Effective amendments for registration..
15/1/202522:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/1/202513:34GLOBESciSparc Granted 180-Day Extension by Nasdaq to Regain..
13/1/202514:41GLOBESciSparc: AutoMax Enters the Direct Import Market with a $13..
07/1/202513:25GLOBESciSparc: MitoCareX Bio Expands Research to Pancreatic..
07/1/202512:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/1/202513:50GLOBESciSparc-Clearmind Medicine Collaboration Announces the..
31/12/202422:16EDGAR2Form F-4/A - Registration of securities, foreign private..
31/12/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/12/202415:24GLOBESciSparc Announces Renewal of Approval by Israeli Medical..
26/12/202422:06EDGAR2Form 425 - Prospectuses and communications, business..
26/12/202422:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/12/202412:46GLOBESciSparc: AutoMax Announces $13 Million First Delivery of..
17/12/202413:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/12/202413:40GLOBESciSparc Provides Updates on Status of Spin-off of its..
29/11/202414:56EDGAR2Form 425 - Prospectuses and communications, business..
29/11/202414:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/11/202422:53EDGAR2Form 425 - Prospectuses and communications, business..
27/11/202422:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/11/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/10/202414:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/10/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/9/202415:25GLOBESciSparc Secures FDA Green Light to US Launch of its Pivotal..
27/9/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202415:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202415:05GLOBESciSparc Signs Non-Binding Letter of Intent to Sell Stake in..
23/9/202415:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/9/202414:17GLOBESciSparc Receives FDA Approval to Initiate Phase IIb..
18/9/202422:09GLOBESciSparc Takes Major Step Forward with IND Application..
16/9/202422:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/9/202422:06GLOBESciSparc-Clearmind Medicine Collaboration Announces the..
11/9/202415:26EDGAR2Form 425 - Prospectuses and communications, business..
11/9/202415:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202413:40GLOBESciSparc Advances $1.85 million Loan to AutoMax, Following..
06/9/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/9/202413:55GLOBESciSparc-Clearmind Medicine Collaboration Leads to..
29/8/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202422:25GLOBESciSparc-Clearmind Medicine Collaboration Leads to..
Apertura: Min: Max:
Chiusura: 0,3285

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network